TABLE 4.

Incident rates of arrhythmia, myocardial infarction, hip fracture, opportunistic infection and sensorineural hearing loss among new users of inhaled corticosteroids and macrolide monotherapy with bronchiectasis

Outcome	Inhaled corticosteroid			Macrolide monotherapy
	Events	Patient-years	Incidence rate #	Events	Patient-years	Incidence rate #
Arrhythmia	9508	31 395	30.3 (29.7–30.9)	728	2855	25.5 (23.7–27.4)
Myocardial infarction	892	34 688	2.6 (2.4–2.8)	81	3171	2.6 (2.0–3.2)
Hip fracture	919	34 661	2.7 (2.5–2.8)	77	3173	2.4 (1.9–3.0)
Opportunistic infection	1585	34 200	4.6 (4.4–4.9)	180	3113	5.8 (5.0–6.7)
Sensorineural hearing loss	2574	33 491	7.7 (7.4–8.0)	347	2993	11.6 (10.4–12.9)

^#: incidence rate per 100 patient-years (95% confidence interval).